Bezetabart Biosimilar - Research Grade

Human

CD74ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P04233;P04441

Blue ice

CD74 functions as the MHC class II invariant chain and as a receptor for macrophage migration inhibitory factor, making it relevant to immunology and B-cell malignancy research. Offered as an unconjugated, non-therapeutic analog of bezetabart, this human IgG1-kappa recombinant antibody is for research use only. It is supplied with low endotoxin to in vivo-grade standards and produced in scalable milligram-to-gram quantities for bulk and high-throughput laboratories. The antibody supports functional assays, antigen-processing and internalization studies, in vitro screening and preclinical models investigating CD74-mediated signaling. Its low-endotoxin, in vivo-grade formulation and scalable milligram-to-gram supply make it dependable for repeat, high-volume experimentation.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks